Seres Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-66.4M | $-69.4M | $3.0M | $5.1M |
| Mar 2023 | $-76.6M | $-80.7M | $4.1M | $6.9M |
| Mar 2024 | $-35.2M | $-35.3M | $62.0K | $6.5M |
| Mar 2025 | $26.9M | $26.9M | $34.0K | $2.8M |
| Mar 2026 | $-16.4M | $-16.4M | $0 | $1.8M |